Xylo Technologies Files its 2023 Annual Report on Form 20-F
2024年4月23日 - 5:05AM
Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo”, or the “Company”),
formerly known as Medigus Ltd., a technology-based company engaged
in advanced innovative technologies, announced the filing of its
2023 Annual Report on Form 20-F with the Securities and Exchange
Commission.
Xylo’s 2023 Annual Report on Form 20-F includes
audited financial statements for the year ended December 31, 2023.
The report can be accessed on the company’s investor relations
website and on the SEC’s website at www.sec.gov.
About Xylo
Based in Israel, Xylo Technologies Ltd. (Nasdaq:
XYLO) is a technologies company that focuses on innovative growth
partnerships, mainly in advanced medical solutions, digital
commerce, and electric vehicle markets. Xylo’s affiliations in
the medical solutions arena include the ownership in Polyrizon Ltd.
Xylo’s affiliates in digital commerce include Gix Internet Ltd.,
Jeffs’ Brands and Eventer Technologies Ltd. In the electric vehicle
market, Fuel Doctor, Inc., Charging Robotics, Ltd. and Revoltz Ltd.
are also part of Xylo’s portfolio of technology solution providers.
Other affiliations of Xylo include Parazero Technologies Ltd. and
Zig Miami 54 LLC.
Xylo is traded on the Nasdaq Capital Market. To
learn more about Xylo’s advanced technologies, please
visit http://www.medigus.com/investor-relations
Company Contact: Tali Dinar Chief Financial
Officerir@medigus.com
Investor Relations Contact: Michal Efraty
Investor Relations,michal@efraty.com
Medigus (NASDAQ:MDGS)
過去 株価チャート
から 8 2024 まで 10 2024
Medigus (NASDAQ:MDGS)
過去 株価チャート
から 10 2023 まで 10 2024